Brief Interventions for Harmful Alcohol Use in Opioid-dependent Patients on Maintenance Treatment With Buprenorphine: A Prospective Study From India

被引:11
|
作者
Varshney, Mohit
Ambekar, Atul [1 ,2 ]
Lal, Rakesh
Yadav, Deepak
Rao, Ravindra
Mishra, Ashwani
机构
[1] All India Inst Med Sci, Dept Psychiat, New Delhi 110029, India
[2] All India Inst Med Sci, Natl Drug Dependence Treatment Ctr, New Delhi 110029, India
关键词
Brief Intervention; harmful alcohol use; buprenorphine; opioid substitution therapy;
D O I
10.1097/ADT.0000000000000076
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Harmful/hazardous alcohol use is common among individuals receiving opioid substitution therapy (OST). The World Health Organisation (WHO) recommends use of Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)-linked Brief Interventions (BI) for managing harmful alcohol use. However, the feasibility and effectiveness of BI in addressing harmful alcohol use among buprenorphine-maintained OST recipients has not been studied, which was the objective of the present study. Methods: Using a prospective study design, OST recipients were screened with WHO-ASSIST, and those in the harmful/hazardous use category were administered BI sessions. The feasibility of BI was assessed using BI process rating form. Alcohol-related quantitative variables were assessed with WHO-ASSIST and Rutgers Alcohol Problem Index at baseline and 12 weeks post-BI, and compared for measuring BI effectiveness. Results: Thirty-six (of 138 OST recipients screened) had ASSIST scores in the harmful hazardous category at baseline, and underwent 2 BI sessions at 1 to 2 weeks apart. Of these, 35 patients completed all BI sessions, and baseline and end-line assessments. The average time taken for 1 BI session was 26.43 minutes; 54% reported a "significant influence'' of BI on alcohol consumption; 88% reported that they attempted to cut down alcohol use; 14% completely stopped drinking; and another 14% reported significant reduction in alcohol consumption. ASSIST and Rutgers Alcohol Problem Index scores were significantly reduced at end-line assessment. Conclusion: BI is a feasible and effective intervention to address harmful/hazardous drinking among buprenorphine-maintained opioid-dependent patients.
引用
收藏
页码:129 / 135
页数:7
相关论文
共 50 条
  • [41] Multicenter Observational/Exploratory Study Addressed to the Evaluation of the Effectiveness and Safety of Pharmacological Therapy in Opioid-Dependent Patients in Maintenance Therapy in Southern Italy
    Maqoud, Fatima
    Fabio, Giada
    Ciliero, Nunzio
    Antonacci, Marina
    Mastrangelo, Francesca
    Sammarruco, Giorgio
    Cataldini, Roberto
    Schirosi, Gabriella
    De Fazio, Salvatore
    Tricarico, Domenico
    PHARMACEUTICS, 2022, 14 (02)
  • [42] Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study
    Strang, John
    Reed, Kylie
    Bogdanowicz, Karolina
    Bell, James
    van der Waal, Rob
    Keen, Jenny
    Beavan, Pete
    Baillie, Shelagh
    Knight, Alastair
    EUROPEAN ADDICTION RESEARCH, 2017, 23 (02) : 61 - 70
  • [43] Patient's perspective on early treatment retention in take home buprenorphine maintenance treatment- an explorative study from India
    M, P.
    Chand, P.
    Murthy, P.
    EUROPEAN PSYCHIATRY, 2021, 64 : S567 - S567
  • [44] Brief interventions are effective in reducing alcohol consumption in opiate-dependent methadone-maintained patients: Results from an implementation study
    Darker, Catherine D.
    Sweeney, Brion P.
    El Hassan, Haytham O.
    Smyth, Bobby P.
    Ivers, Jo-Hanna H.
    Barry, Joe M.
    DRUG AND ALCOHOL REVIEW, 2012, 31 (03) : 348 - 356
  • [45] Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study
    John, Samuel
    Boorman, David W.
    Potru, Sudheer
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (02) : E94 - E100
  • [46] Baseline Factors Associated with Mortality in Patients Who Engaged in Buprenorphine Treatment for Opioid Use Disorder: a Cohort Study
    Fine, Danielle R.
    Yu, Liyang
    Triant, Virginia A.
    Baggett, Travis P.
    Metlay, Joshua P.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (08) : 2375 - 2382
  • [47] Baseline Factors Associated with Mortality in Patients Who Engaged in Buprenorphine Treatment for Opioid Use Disorder: a Cohort Study
    Danielle R. Fine
    Liyang Yu
    Virginia A. Triant
    Travis P. Baggett
    Joshua P. Metlay
    Journal of General Internal Medicine, 2020, 35 : 2375 - 2382
  • [48] Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study
    Rapeli, Pekka
    Fabritius, Carola
    Kalska, Hely
    Alho, Hannu
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2012, 7
  • [49] An Exploratory Study of Sex and Gender Differences in Demographic, Psychosocial, Clinical, and Substance Use Treatment Characteristics of Patients in Outpatient Opioid Use Disorder Treatment With Buprenorphine
    Parlier-Ahmad, Anna Beth
    Martin, Caitlin E.
    Radic, Maja
    Svikis, Dace S.
    TRANSLATIONAL ISSUES IN PSYCHOLOGICAL SCIENCE, 2021, 7 (02) : 141 - 153
  • [50] Patterns of patient discontinuation from buprenorphine/naloxone treatment for opioid use disorder: A study of a commercially insured population in Massachusetts
    Hasan, Md Mahmudul
    Noor-E-Alam, Md
    Mohite, Prathamesh
    Islam, Md Saiful
    Modestino, Alicia Sasser
    Peckham, Alyssa M.
    Young, Leonard D.
    Young, Gary J.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 131